Imagine getting a testosterone injection every 10–14 weeks instead of every week. That's the promise of injectable testosterone undecanoate — marketed as Aveed in the US and Nebido internationally. It's the longest-acting injectable testosterone available, and for men who value minimal injection frequency above all else, it's worth understanding.
How It Works
Testosterone undecanoate uses a very long ester chain (11 carbons) dissolved in castor oil. The combination produces an extremely slow-release depot at the injection site. After intramuscular injection into the gluteal muscle, testosterone releases gradually over months, maintaining levels within the normal range for 10–14 weeks before the next injection is needed.
| Property | Detail |
|---|---|
| Half-life | ~33 days (longest of any injectable T ester) |
| Injection interval | Every 10 weeks (after initial loading) or every 12–14 weeks (Nebido) |
| Injection volume | 3 mL (large volume — gluteal IM only) |
| Carrier oil | Castor oil |
| Administration | Must be administered in-office by a healthcare professional (Aveed REMS) |
The REMS Restriction
Aveed carries a Risk Evaluation and Mitigation Strategy (REMS) requirement because of rare but serious post-injection reactions — specifically, pulmonary oil microembolism (POME) and anaphylaxis. Symptoms of POME include cough, shortness of breath, chest tightness, and dizziness occurring immediately after injection.
Because of this risk, Aveed must be administered in a healthcare facility by a trained professional, and patients must be observed for 30 minutes after each injection. You cannot self-inject Aveed at home.
The in-office requirement is the primary barrier to adoption. Men who chose telehealth TRT specifically to avoid office visits find the mandatory in-person injection appointment every 10 weeks contradictory to their goals.
Who Benefits Most
Good Candidates for Undecanoate Injections
- Injection-averse men who prefer 5–6 injections per year over 52–104
- Compliance-challenged men who struggle with consistent weekly self-injection
- Travelers who don't want to carry injectable supplies
- Men comfortable with in-office visits — the REMS requirement makes this mandatory
The Downsides
- Wide peak-trough variance: Despite the long half-life, some men experience declining testosterone effects in the final 2–3 weeks before their next injection. The 10–14 week interval doesn't produce perfectly stable levels for everyone.
- Cost: Aveed is expensive — $1,000–$1,500 per injection without insurance, or $5,000–$8,000/year. Insurance coverage varies but is often available with prior authorization for diagnosed hypogonadism.
- Large injection volume: 3 mL into the gluteal muscle. This is substantially more than the 0.3–0.5 mL typical of self-administered cypionate, and post-injection soreness is common.
- No dose flexibility: Aveed comes in a fixed 750mg dose. You can't easily titrate the way you can with weekly cypionate.
The Bottom Line
Maximum Convenience With Trade-offs
Injectable testosterone undecanoate offers the lowest injection frequency available — 5–6 per year. The trade-offs are in-office administration (mandatory), high cost, large injection volume, and less dose flexibility. For men who prioritize minimal injection frequency and don't mind in-office visits, it's a legitimate option. For men who value the control and flexibility of self-administered weekly cypionate, it's likely not the right fit.